Brief: Pharmesis International Proposes To Buy 30 Pct Stake In Sichuan Longlife
31/12/2018 11:49
Dec 31 (Reuters) - Pharmesis International Ltd PHAR.SI :
* PROPOSES ACQUISITION OF 30% OF EQUITY INTEREST IN SICHUAN
LONGLIFE
* UNIT ENTERS SALE AND PURCHASE GREEMENT TO BUY 30% STAKE IN
SICHUAN LONGLIFE PHARMACEUTICAL CO FROM CHENGDU KINNA INVESTMENT
CO
* AGGREGATE PURCHASE CONSIDERATION SHALL BE SUM OF RMB15.7
MILLION
Source text for Eikon: ID:nSNZc7Pnct
Further company coverage: PHAR.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmesis International
See all newsPharmesis H1 revenue falls 56% amid challenging operating environment
Brief: Pharmesis International Sees Net Loss For HY
Brief: Pharmesis International Says Proposing To Undertake Capital Reduction Exercise
Brief: Pharmesis International Sees Net Profit For 6M & FY Ended 31 Dec 2024
Brief: Pharmesis International Says Unit Entered Conditional Sale And Purchase Agreement